Related Experiment Video
Updated: Aug 9, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Relationship between coronary heart disease and chronic renal insufficiency
1National Centre of Therapy, Tbilisi, Georgia.
Insights
Coronary heart disease (CHD) patients with chronic renal insufficiency (CRI) exhibit more severe symptoms and higher blood pressure. Dyslipidemia is more pronounced in these patients, correlating positively with renal damage, indicating a heavier disease course.
Area of Science:
- Cardiology
- Nephrology
- Public Health
Background:
- Coronary heart disease (CHD) is a significant global health concern.
- The co-occurrence of CHD with chronic renal insufficiency (CRI) is increasing.
- Understanding risk factors in CHD patients with CRI is crucial for public health.
Purpose of the Study:
- To investigate the connection between CHD and risk factors in patients with CRI.
- To compare clinical and biochemical parameters between CHD patients with and without CRI.
- To identify correlations between lipid profiles, blood pressure, and renal function in CHD patients.
Main Methods:
- Study included 78 patients: 33 with CHD (Group I), 25 with CHD and CRI (Group II), and 20 healthy controls (Group III).
- Lipid spectrum analysis was performed using "Janway 4500" spectrometry and "BIOLABO" enzyme tests.
- Statistical analysis included Student-t test and Pearson's correlation, with significance set at p<0.05.
Main Results:
- Group II (CHD with CRI) showed significantly higher blood pressure (172/94 mmHg) compared to Group I (CHD only) (162/88 mmHg).
- Dyslipidemia was significantly more pronounced in CHD patients with CRI than in those without.
- Abnormal lipid spectrum in Group II positively correlated with renal damage.
Conclusions:
- CHD with CRI presents a more severe clinical course than CHD alone.
- Complex changes in lipid profiles and elevated blood pressure are key factors in the progression of CHD in patients with CRI.
- Early detection and management of dyslipidemia and hypertension are vital for CHD patients with coexisting renal insufficiency.
Abstract:
Coronary heart disease (CHD) is a worldwide public health problem. CHD is 100 times more prevalent than CHD with Chronic renal insufficiency (CRI), and its incidence is increasing at an even faster rate. The aim of this work is to determine the connection between CHD and risk factors in CHD patients with CRI. There were 78 patients (age 54,46+/-12,46 years), 45 males and 33 female. In group I were included 33 patients with CHD (57,7+/-9,03 years, in group II - 25 patients with CHD and CRI (59,35+/-10,64 years). The control group III - was composed of practically healthy persons 20 (40,7+/-12,6 years). Lipid spectrum was studied in blood serum using "Janway 4500" spectrometry, by the enzyme method using "BIOLABO" test (France). The received data was treated statistically M+/-SD(M-mean SD-standard deviation (SD). Student-t test was used for the analysis of the data obtained for the groups, statistical appearance was determined as p<0,05. Correlation was tested according to the Person's correlation. Data of our studies showed, that in group II level of lipid spectrum is lower than in group II. We suggested that these complex changes in lipid profiles may significantly contribute to the heavy pass CHD. Increased level of IA results from complex changes in lipid profiles. In group II the blood pressure (BP) is significantly (p<0,05) higher (172/94 mm/hg) than in group I (162/88 mm/hg). By literature a primary kidney defect can produce hypertension or increase a level of BP. According to our observation, dyslipidemia is significantly expressed in CHD patients with CRI, than without CRI. Data of our studies showed, that abnormal lipid spectrum is positively correlated with renal damage. Therefore, we can conclude CHD with CRI passes heavier than CHD without CRI.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Heart Failure Drugs: Diuretics
Coronary Artery Disease IV: Preventive Measures
